Bio-Techne
TECH
#2005
Rank
A$11.92 B
Marketcap
$75.41
Share price
-3.75%
Change (1 day)
-22.12%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

EPS for Bio-Techne (TECH)

EPS in 2023 (TTM): $2.36

According to Bio-Techne's latest financial reports the company's current EPS (TTM) is $2.46. In 2022 the company made an earnings per share (EPS) of $2.62 an increase over its 2021 EPS that were of $2.11.

EPS history for Bio-Techne from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.36-9.88%
2022$2.6224.35%
2021$2.1117.98%
2020$1.79-10.94%
2019$2.01101.57%
2018$1.00-17.53%
2017$1.2139.37%
2016$0.87-17.23%
2015$1.05-14.97%
2014$1.231.29%
2013$1.223.68%
2012$1.17-1.97%
2011$1.201.67%
2010$1.187.14%
2009$1.10-1.06%
2008$1.1119.41%
2007$0.9319.1%
2006$0.7810.56%
2005$0.7129.5%
2004$0.5413.05%
2003$0.4868.43%
2002$0.29-17.05%
2001$0.3417.33%
2000$0.2948.51%
1999$0.2023.17%
1998$0.1613.89%
1997$0.1442.57%
1996$0.09897

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$24.05 877.07%๐Ÿ‡บ๐Ÿ‡ธ USA
-$8.97-464.33%๐Ÿ‡บ๐Ÿ‡ธ USA
$8.70 253.50%๐Ÿ‡บ๐Ÿ‡ธ USA
$12.57 410.83%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.28-7.38%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
$13.40 444.59%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.47-159.87%๐Ÿ‡บ๐Ÿ‡ธ USA